Tiansheng Pharmaceutical Group Co., Ltd. (SHE:002872)
China · Delayed Price · Currency is CNY 5.46
-0.04 (-0.73%)
Jun 2, 2026, 3:04 PM CST
SHE:002872 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | -56.01 | -87.4 | -93.07 | -90.56 | -67.81 |
Depreciation & Amortization | 122.14 | 107.06 | 107.26 | 107.72 | 89.99 |
Other Amortization | 4.51 | 5.84 | 2.83 | 2.76 | 3.25 |
Loss (Gain) From Sale of Assets | 0.16 | -0.04 | -0.23 | -9.53 | -5.22 |
Asset Writedown & Restructuring Costs | 10.03 | 24.18 | 4.81 | 3.21 | 8.48 |
Loss (Gain) From Sale of Investments | -6.08 | -16.56 | -2.01 | -4.92 | -4.57 |
Provision & Write-off of Bad Debts | - | -0.78 | 4.24 | 1.27 | 17.58 |
Other Operating Activities | 28.07 | 43.86 | 29.45 | 31.88 | 10.6 |
Change in Accounts Receivable | 16.41 | 15.65 | 103.03 | 54.68 | -419.09 |
Change in Inventory | -0.02 | 28.03 | 49.47 | -6.86 | 167.57 |
Change in Accounts Payable | -71.33 | -61.96 | -231.1 | -4.71 | 187.8 |
Change in Other Net Operating Assets | - | 2.09 | 2.16 | - | - |
Operating Cash Flow | 42.97 | 50.15 | -24.56 | 89.18 | 18.97 |
Operating Cash Flow Growth | -14.31% | - | - | 370.09% | -90.00% |
Capital Expenditures | -26.92 | -50.27 | -76.74 | -73.42 | -114.38 |
Sale of Property, Plant & Equipment | 5.82 | 0.09 | 15.05 | 14.88 | 36.34 |
Cash Acquisitions | - | - | -30 | - | -29.4 |
Divestitures | - | - | - | 22.45 | 31.08 |
Investment in Securities | -1.31 | 30 | - | 82 | -72.7 |
Other Investing Activities | 5.99 | 25.75 | 156.6 | 6.12 | 318.64 |
Investing Cash Flow | -16.41 | 5.57 | -82.08 | -65.57 | 169.58 |
Long-Term Debt Issued | 159.3 | 282.5 | 213.3 | 101 | 226.74 |
Long-Term Debt Repaid | -155.78 | -221.85 | -208.97 | -167.53 | -358.33 |
Net Debt Issued (Repaid) | 3.52 | 60.65 | 4.33 | -66.53 | -131.59 |
Issuance of Common Stock | - | 5.2 | - | - | - |
Common Dividends Paid | -14.97 | -15.26 | -15.54 | -15.94 | -22.89 |
Other Financing Activities | -1.33 | -0.04 | - | 38 | 15.51 |
Financing Cash Flow | -12.79 | 50.56 | -11.2 | -44.47 | -138.97 |
Net Cash Flow | 13.77 | 106.27 | -117.85 | -20.85 | 49.58 |
Free Cash Flow | 16.05 | -0.13 | -101.3 | 15.76 | -95.41 |
Free Cash Flow Margin | 3.12% | -0.02% | -17.49% | 2.60% | -12.95% |
Free Cash Flow Per Share | 0.05 | - | -0.32 | 0.05 | -0.30 |
Cash Income Tax Paid | 45.92 | 48.51 | 60.49 | 22.19 | 24.21 |
Levered Free Cash Flow | 74.79 | 57.93 | -57.8 | -37.29 | 171.75 |
Unlevered Free Cash Flow | 74.79 | 67.17 | -48.43 | -27.43 | 186.97 |
Change in Working Capital | -59.85 | -26 | -77.84 | 47.35 | -33.34 |